DDrare: Database of Drug Development for Rare Diseases

Searched query = "Purpura nephritis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Drug = ACEI; Acetate; Adrenal cortical hormone; Adrenergic receptor binder (ARB); Angiotensin; Angiotensin-converting enzyme (ACE) inhibitor; Angiotensin-converting enzyme inhibitor(ACEI); Benazepril; Benazepril Hydrochloride Tablets; Calcium; Chinese herbs based on syndrome differentiation; Cyclophosphamide; Cyclophosphamide(CTX); Dipyridamole; Dipyridamole Tab 25 MG; Glycosides Of Tripterygium Wilfordii Hook(GTW); Gold; Heparin; Huaiqinhuang; Immunosuppressant; Leflunomide; Leflunomide(LEF); Low Molecular Weight Heparin Calcium Injection; MMF; Methylprednisolone; Mizoribine; Mycophenolate; Mycophenolate mofetil; Mycophenolate mofetil(MMF); Prednisone; Prednisone Acetate Tablets; Prednisone acetate; Qi-Ji Shen-Kang formula; Sulfotanshinone Sodium Injection; Tacrolimus; Tripterygium; Tripterygium Wilfordii; Tripterygium wilfordii polyglycosidium; Valsartan; Yu-Shen formula; Zhu-Bai formula

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02878018 (ClinicalTrials.gov)	September 2016	17/8/2016	Cohort Study on Traditional Chinese Medicine Diagnosis and Treatment of Children With Henoch-Schonlein Purpura Nephritis	Cohort Study on Traditional Chinese Medicine Diagnosis and Treatment of Children With Henoch-Schonlein Purpura Nephritis	Henoch-Schonlein Purpura Nephritis	Drug: Qi-Ji Shen-Kang formula; Zhu-Bai formula; Yu-Shen formula;Drug: angiotensin -converting enzyme (ACE) inhibitor; adrenergic receptor binder (ARB); adrenal cortical hormone; Tripterygium wilfordii polyglycosidium; immunosuppressant	Liaoning University of Traditional Chinese Medicine	First Hospital of China Medical University;Shengjing Hospital	Active, not recruiting	5 Years	18 Years	All	600		China
2	NCT02532777 (ClinicalTrials.gov)	August 2015	20/8/2015	The Research of Standard Diagnosis and Treatment for HSPN in Children	The Research of Standard Diagnosis and Treatment for Henoch-Schonlein Purpura Nephritis in Children	Henoch-Schoenlein Purpura Nephritis	Drug: Prednisone;Drug: Cyclophosphamide (CTX);Drug: Mycophenolate mofetil (MMF);Drug: Leflunomide (LEF);Drug: Angiotensin -converting enzyme inhibitor(ACEI);Drug: Methylprednisolone	Nanjing Children's Hospital	NULL	Recruiting	2 Years	16 Years	All	100	Phase 2	China

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT02878018
(ClinicalTrials.gov)

September 2016

17/8/2016

Cohort Study on Traditional Chinese Medicine Diagnosis and Treatment of Children With Henoch-Schonlein Purpura Nephritis

Henoch-Schonlein Purpura Nephritis

Drug: Qi-Ji Shen-Kang formula; Zhu-Bai formula; Yu-Shen formula;Drug: angiotensin -converting enzyme (ACE) inhibitor; adrenergic receptor binder (ARB); adrenal cortical hormone; Tripterygium wilfordii polyglycosidium; immunosuppressant

Liaoning University of Traditional Chinese Medicine

First Hospital of China Medical University;Shengjing Hospital

Active, not recruiting

5 Years

18 Years

All

600

China

NCT02532777
(ClinicalTrials.gov)

August 2015

20/8/2015

The Research of Standard Diagnosis and Treatment for HSPN in Children

The Research of Standard Diagnosis and Treatment for Henoch-Schonlein Purpura Nephritis in Children

Henoch-Schoenlein Purpura Nephritis

Drug: Prednisone;Drug: Cyclophosphamide (CTX);Drug: Mycophenolate mofetil (MMF);Drug: Leflunomide (LEF);Drug: Angiotensin -converting enzyme inhibitor(ACEI);Drug: Methylprednisolone

Nanjing Children's Hospital

NULL

Recruiting

2 Years

16 Years

All

100

Phase 2

China